FUNDAMENTAL PARADIGMS IN CLINICAL PHARMACOLOGY: A DUAL PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMIC EVALUATION OF POLYPHARMACY IN CHRONIC METABOLIC DISORDERS. Res. Jou. Ana.Inv. 2026, 7 (5), 1-8. https://doi.org/10.17605/.